Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (681-690 of 824) with videos related to

Pageof 83
Sort By:
International Journal of Molecular Sciences|April 26, 2016
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialKun-Chun Chiang, Ta-Sen Yeh, Shin-Cheh Chen, et al.
Plos One|July 26, 2022
Delirium and its association with short-term outcomes in younger and older patients with acute heart failureJin H Han, Candace D McNaughton, William B Stubblefield, et al.
Tropical Biomedicine|October 10, 2022
Advances in the study of molecular identification technology of Echinococcus speciesR J Zhang, J Z Li, H S Pang, et al.
Cancer Letters|August 24, 2014
The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Plos Pathogens|August 13, 2021
Abrupt and altered cell-type specific DNA methylation profiles in blood during acute HIV infection persists despite prompt initiation of ARTMichael J Corley, Carlo Sacdalan, Alina P S Pang, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
American Heart Journal|September 24, 2017
Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency DepartmentHanna Kim Gaggin, Annabel Angela Chen-Tournoux, Robert H Christenson, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Hepatology (Baltimore, Md.)|May 13, 2015
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trialsSaleh A Alqahtani, Nezam Afdhal, Stefan Zeuzem, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2023
Disconnect between the effects of serelaxin on renal function and outcome in acute heart failureI E Beldhuis, J M Ter Maaten, S M Figarska, et al.
Pageof 83

Showing results (681-690 of 824) with videos related to

Sort By:
Pageof 83
International Journal of Molecular Sciences|April 26, 2016
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic PotentialKun-Chun Chiang, Ta-Sen Yeh, Shin-Cheh Chen, et al.
Plos One|July 26, 2022
Delirium and its association with short-term outcomes in younger and older patients with acute heart failureJin H Han, Candace D McNaughton, William B Stubblefield, et al.
Tropical Biomedicine|October 10, 2022
Advances in the study of molecular identification technology of Echinococcus speciesR J Zhang, J Z Li, H S Pang, et al.
Cancer Letters|August 24, 2014
The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Plos Pathogens|August 13, 2021
Abrupt and altered cell-type specific DNA methylation profiles in blood during acute HIV infection persists despite prompt initiation of ARTMichael J Corley, Carlo Sacdalan, Alina P S Pang, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
American Heart Journal|September 24, 2017
Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency DepartmentHanna Kim Gaggin, Annabel Angela Chen-Tournoux, Robert H Christenson, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Hepatology (Baltimore, Md.)|May 13, 2015
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trialsSaleh A Alqahtani, Nezam Afdhal, Stefan Zeuzem, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2023
Disconnect between the effects of serelaxin on renal function and outcome in acute heart failureI E Beldhuis, J M Ter Maaten, S M Figarska, et al.
Pageof 83